Page 25 - Read Online
P. 25

analyzed by 2% agarose gel electrophoresis. The cut site   Considering the difference in mean age between the
            for Tr  u1I (MseI) was 5’-TTAA-3’.                two study groups, we analyzed polymorphisms of
                                                              CTLA-4 gene in all participants according to age groups
            The   digested fragments in 1661AG were 139 and 347 bp.
            Presence of the  A allele was recognized by detecting   of under or over 40 years, but found no signifi cant
            digested 347 and 139 bp fragments on gel  , and the G   difference (P = 0.30) [Table 1].  We determined that
            allele by detecting intact primary 486 bp band [Figure 1].   the age difference between the two groups had no
            Comparisons of genotype and allele frequencies in cases   confounding effect on the study results.
            and controls were assessed by Chi-square and  t-test   Analysis of metastasis showed that there is a signifi cant
            using  SPSS-16.0 (SPSS Inc., Chicago, USA). Statistical   relationship between  CTLA-4 gene polymorphism and
            software and statistical signifi cance were set at P ≤ 0.05. The   metastasis. Patients with AA genotype had higher rates of
            odds ratio and 95% confi dence interval were also calculated.  metastasis (P = 0.02) [Table 1].

            Results                                           Analysis  also  showed  no   relationship  between
                                                              CTLA-4 gene polymorphisms and ER (P = 0.49),
            A total of 100 women with breast cancer and       progesterone receptor (P = 0.15) and lymph node
            100 healthy controls were enrolled in this study. Mean   involvement (P = 0.53) [Table 1].
            age of the case group was 48.92 ± 9.85 years and of
            the control group was 37.92 ± 13.67 years (P < 0.001;   Discussion
            t-test).  This study was done in patients who presented
            at Shahid Sadughi Hospital and Cancer Hospital, Yazd,   There is increasing attention to the relationship
            Iran. The grade, stage and size of the tumor in the case   between several genes’ polymorphisms and polygenetic
            group are shown in  Table 1.  About 73.3% of patients   diseases such as hypertension, diabetes, and various
                                                                         [28]
            had grade one tumors, and about 75% had stages 1 and   malignancies.  T cells and NK cells have a substantial
                                                                                              [29]
            2 tumors.  Tumor size in more than 60.9% of patients   role in working against tumors.  T-lymphocyte,
            was ≤ 2 mm.                                       especially T killer cell, is the most important in defending
                                                              cells against tumors. CTLA-4 molecule expresses
            Polymorphisms of  CTLA-4 gene are shown in Figure 2.   on  T-lymphocyte as an inhibitor and plays different
            There is a signifi cant relationship between groups   roles in  T-cell activity. It could inhibit amplifi cation  of
            according to gene polymorphisms (P = 0.03). Frequency   T cells or even induce apoptosis of activated  T cells.
                                                                                                           [30]
            of AA polymorphisms in the case group is higher than in   CTLA-4-mediated suppression of tumor immunity has
            controls whereas  AG polymorphisms are more frequent   been previously reported.  Several studies have
                                                                                      [13]
            in the control group.                             demonstrated the effect of CTLA-4 blockade in enhancing
            Table 1 shows polymorphisms according to tumor    immunity to tumors. [14-16]   There are some studies on
            stage.  There is no signifi cant difference among study   the relationship between  CTLA-4 gene polymorphisms
                                                                                                         [31]
            groups according to tumor grade (P = 0.21). Also there   and breast cancer, but results were contradictory.  In
            was no relationship between polymorphism and tumor   order to clarify the role of genetic variants of  CTLA-4
            stage (P = 0.50) and tumor size (P = 0.50).       gene in immune suppression of patients with cancer,
                                                              the distribution of  CTLA-4 gene single nucleotide
                                                              polymorphisms (1661AG), in breast cancer patients and


                                                               80
                                                                                 69
                                                               70
                                                                                            60
                                                               60
                                                                      51
                                                               50
                                                                    43
                                                                                        35.5
                                                               40
                                                                              28
                                                               30
                                                               20
                                                                          6
                                                               10                             4.5
                                                                                    3
                                                                0
                                                                   Patients group  Controls  Total
                                                                                AA   AG   GG
                                                              Figure 2:  Frequency of AA, AG and GG polymorphisms of cytotoxic
            Figure 1: A gel image for the polymerase chain reaction-restriction fragment   T-lymphocyte antigen-4 gene in patients, controls and total study group,
            length polymorphism experiment which illustrates the band patterns of   showing that AA genotype in patients is more than this genotype in controls
            AA, AG and GG genotypes. Line M: molecular weight marker; Line 1:   while AG polymorphism is more frequent in the control group. The Y-axis is
            AG genotype; Lines 2 and 4: GG genotype; Line 3: AA genotype; Line 5:   showing the number of the cases and the X-axis is showing different types
            negative control                                  of genotypes

            18                                      Journal of Cancer Metastasis and Treatment  ¦  Volume 1 ¦ Issue 1 ¦ April 15, 2015 ¦
   20   21   22   23   24   25   26   27   28   29   30